257 related articles for article (PubMed ID: 33205060)
1. Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs
Pache L; Marsden MD; Teriete P; Portillo AJ; Heimann D; Kim JT; Soliman MSA; Dimapasoc M; Carmona C; Celeridad M; Spivak AM; Planelles V; Cosford NDP; Zack JA; Chanda SK
Cell Rep Med; 2020 Jun; 1(3):100037. PubMed ID: 33205060
[TBL] [Abstract][Full Text] [Related]
2. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
[TBL] [Abstract][Full Text] [Related]
3. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
4. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
[TBL] [Abstract][Full Text] [Related]
5. Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo.
Nixon CC; Mavigner M; Sampey GC; Brooks AD; Spagnuolo RA; Irlbeck DM; Mattingly C; Ho PT; Schoof N; Cammon CG; Tharp GK; Kanke M; Wang Z; Cleary RA; Upadhyay AA; De C; Wills SR; Falcinelli SD; Galardi C; Walum H; Schramm NJ; Deutsch J; Lifson JD; Fennessey CM; Keele BF; Jean S; Maguire S; Liao B; Browne EP; Ferris RG; Brehm JH; Favre D; Vanderford TH; Bosinger SE; Jones CD; Routy JP; Archin NM; Margolis DM; Wahl A; Dunham RM; Silvestri G; Chahroudi A; Garcia JV
Nature; 2020 Feb; 578(7793):160-165. PubMed ID: 31969707
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.
Yang HC; Xing S; Shan L; O'Connell K; Dinoso J; Shen A; Zhou Y; Shrum CK; Han Y; Liu JO; Zhang H; Margolick JB; Siliciano RF
J Clin Invest; 2009 Nov; 119(11):3473-86. PubMed ID: 19805909
[TBL] [Abstract][Full Text] [Related]
7. HIV latency in the humanized BLT mouse.
Marsden MD; Kovochich M; Suree N; Shimizu S; Mehta R; Cortado R; Bristol G; An DS; Zack JA
J Virol; 2012 Jan; 86(1):339-47. PubMed ID: 22072769
[TBL] [Abstract][Full Text] [Related]
8. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response.
Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131
[TBL] [Abstract][Full Text] [Related]
9. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
[TBL] [Abstract][Full Text] [Related]
10. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
[TBL] [Abstract][Full Text] [Related]
11. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S
Front Immunol; 2021; 12():720697. PubMed ID: 34531866
[TBL] [Abstract][Full Text] [Related]
12. The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate.
Bobardt M; Kuo J; Chatterji U; Chanda S; Little SJ; Wiedemann N; Vuagniaux G; Gallay PA
PLoS One; 2019; 14(2):e0211746. PubMed ID: 30716099
[TBL] [Abstract][Full Text] [Related]
13. BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.
Pache L; Dutra MS; Spivak AM; Marlett JM; Murry JP; Hwang Y; Maestre AM; Manganaro L; Vamos M; Teriete P; Martins LJ; König R; Simon V; Bosque A; Fernandez-Sesma A; Cosford ND; Bushman FD; Young JA; Planelles V; Chanda SK
Cell Host Microbe; 2015 Sep; 18(3):345-53. PubMed ID: 26355217
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation.
Jiang G; Mendes EA; Kaiser P; Wong DP; Tang Y; Cai I; Fenton A; Melcher GP; Hildreth JE; Thompson GR; Wong JK; Dandekar S
PLoS Pathog; 2015 Jul; 11(7):e1005066. PubMed ID: 26225771
[TBL] [Abstract][Full Text] [Related]
15. Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation.
Bosque A; Nilson KA; Macedo AB; Spivak AM; Archin NM; Van Wagoner RM; Martins LJ; Novis CL; Szaniawski MA; Ireland CM; Margolis DM; Price DH; Planelles V
Cell Rep; 2017 Jan; 18(5):1324-1334. PubMed ID: 28147284
[TBL] [Abstract][Full Text] [Related]
16. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.
Jiang G; Mendes EA; Kaiser P; Sankaran-Walters S; Tang Y; Weber MG; Melcher GP; Thompson GR; Tanuri A; Pianowski LF; Wong JK; Dandekar S
AIDS; 2014 Jul; 28(11):1555-66. PubMed ID: 24804860
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin antagonizes HIV-1 latency by activating NF-κB without causing global T cell activation.
Zhu X; Liu S; Wang P; Qu X; Wang X; Zeng H; Chen H; Zhu H
Biochem Biophys Res Commun; 2014 Jul; 450(1):202-7. PubMed ID: 24878527
[TBL] [Abstract][Full Text] [Related]
19. The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
Macedo AB; Levinger C; Nguyen BN; Richard J; Gupta M; Cruz CRY; Finzi A; Chiappinelli KB; Crandall KA; Bosque A
J Virol; 2022 Aug; 96(15):e0037222. PubMed ID: 35867565
[TBL] [Abstract][Full Text] [Related]
20. NF-κB sub-pathways and HIV cure: A revisit.
Wong LM; Jiang G
EBioMedicine; 2021 Jan; 63():103159. PubMed ID: 33340992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
